US Surgitech Announces Contractual Agreement with Vizient


CAROL STREAM, Ill., January 31, 2022 /PRNewswire/ — US Surgitech Inc., a medical device company that brings safety and efficiency to the operating room through its innovative product lines, today announced that from January 1, 2022they won a contract in the patient positioning category with Vizient. Vizient is one of the largest healthcare performance improvement companies in the United States, serving approximately half of the nation’s acute care providers, including 97% of academic medical centers, representing approximately $110 billion in annual purchase volume.

The SurgyPad, a patient positioning system from Trendelenburg, will be the flagship product of the agreement, providing facilities with an all-in-one patient positioning system for laparoscopic and robotic surgeries in the specialties of general, gynecology, urology , uro-gyn and Colorectal. Also included in the contract are the headrest and the face positioner.

The SurgyPad features a six-strap system, grip tape, and built-in arm guards to keep the patient secure and improve patient safety. Two sizes are available: a standard 36″ pad and a longer 48″ pad. Some surgical procedures require the operating room table to tilt to varying degrees, making the SurgyPad a crucial part of these procedures to prevent patient injury.

President of US Surgitech, Maaz Meah States,”Offering Vizient members the SurgyPad at a negotiated price as part of this contract represents an important milestone for our organization. It is essential that the operating room be prepared for the safety of their patients. The SurgyPad design is unique from other positioners in the industry. It’s a solution I developed after spending years in the OR and seeing firsthand the difficulties the pre-operative team faces when trying to position a patient safely.”

For more information on US Surgitech or The SurgyPad:

Marketing Department of Surgitech in the United States
(800) 970-4877
[email protected]

SOURCE United States Surgitech Inc.


Comments are closed.